Navigation Links
NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
Date:5/13/2008

To date, NicOx has received euro 19.2 million from Merck under this agreement. NicOx also stands to receive potential additional milestone payments of euro 269 million and industry standard royalties on the sales of products which result from the agreement. Furthermore, NicOx has the option to co-promote resulting products, on a fee-for-detail basis, to specialist physicians in the United States and certain major European countries.

"We are delighted that less than one year after the first drug candidate entered human testing, we now have three drug candidates identified and that the first of these has started patient dosing," said Michele Garufi, Chairman and CEO of NicOx. "We look forward to continued rapid progress in our collaboration with Merck and to the future introduction of a new anti-hypertensive class on the market."

NicOx (Bloomberg: COX:FP, Reuters: NCOX.PA) is a product-driven biopharmaceutical company dedicated to the development and future commercialization of investigational drugs for unmet medical needs. NicOx is applying its proprietary nitric oxide-donating technology to develop an internal portfolio of NCEs in the therapeutic areas of inflammatory and cardio-metabolic disease.

Resources are focused on the development of naproxcinod, a proprietary NCE and the first compound in the Cyclooxygenase Inhibiting Nitric Oxide-Donating (CINOD) class of anti-inflammatory agents, which is in phase 3 clinical studies for the treatment of the signs and symptoms of osteoarthritis, with final phase 3 results anticipated in 2008.

Beyond naproxcinod, NicOx has a pipeline containing multiple nitric oxide-donating NCEs, which are in development internally and with partners, including Pfizer Inc and Merck & Co., Inc., for the treatment of prevalent and underserved diseases, such as atherosclerosis, hypertension, glaucoma and Chronic Obstructive Pulmonary Disease (COPD).

NicOx S.A. is headquartered in France and is listed on the Eu
'/>"/>

SOURCE NicOx S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
2. NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology
3. NicOx Naproxcinod ABPM Data Presented at American Heart Association
4. NicOx Naproxcinod Phase 3 Results Presented at American College of Rheumatology
5. NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020
6. NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update
7. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
8. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... , July 11, 2014 Neurelis, Inc. ("Neurelis") ... to end the option held by Biotie to purchase ... development of NRL-1 (intranasal diazepam) for pediatric and adult ... Over the past year, Biotie has advanced the development ... for the pivotal clinical work required for NDA submission ...
(Date:7/10/2014)... , July 10, 2014  Breg, Inc., a ... has launched the FreeRunner™ knee brace with new ... from patella mal-tracking return to active lifestyles.  FreeRunner,s ... other braces, providing support when patients need it ... they don,t. Patellofemoral issues are the ...
(Date:7/10/2014)... , July 10, 2014  BC Technical, the ... MiE America , Inc., a leading provider of ... into a long-term agreement naming BC Technical as the ... MiE and BC Technical announced today ... to establish BC Technical as the service and systems ...
Breaking Medicine Technology:Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2
... 2011 PRA International, a leading Clinical Research Organization, announces ... upcoming Partnerships in Clinical Trials and Late Phase Drug Development ... Mike Hill, Project Manager for PRA,s Late Phase Services ... Development conference in Boston, MA on 23 March at 11:10 ...
... March 23, 2011 NephRx Corporation today announced ... novel peptide NX002, which currently is in preclinical ... NephRx reported that NX002 had demonstrated significant efficacy ... mucositis.  Mucositis is a debilitating and often dose-limiting ...
Cached Medicine Technology:PRA International Experts to Speak at Industry Events 2NephRx Corp. Awarded New U.S. Patent for Oral Mucositis Agent NX002 2NephRx Corp. Awarded New U.S. Patent for Oral Mucositis Agent NX002 3
(Date:7/12/2014)... Security Analytics market is estimated to grow from $1,961.8 ... an expected CAGR of 9.7% for the period between ... number of security breaches, continued line of sophisticated attacks, ... are enormous. Vendors in the security analytics market are ... better and more secure systems. , There has been ...
(Date:7/12/2014)... July 12, 2014 Casinos ... despite rising competition from international and online casinos. Revenue ... over the five years through 2014-15. Greater per capita ... more gaming services. Rises in discretionary income levels have ... money on non-essential items such as casino gambling services. ...
(Date:7/12/2014)... 12, 2014 "The second toes cross over ... painful to wear shoes," said an inventor from East Hartford, ... prevents this from happening. , He then created a prototype ... prevent the second and big toes from overlapping. This avoids ... shoes. Ergonomic and easy to use, it's ideal for people ...
(Date:7/12/2014)... 12, 2014 Using and carrying around ... two inventors from Ashland, Va., decided that there needed ... inspired us to conceive of our design," he said. ... KIDNEY KOVER, which provides an inconspicuous way to use ... as well as promotes comfort and peace of mind. ...
(Date:7/12/2014)... 2014 For those who are unfamiliar with ... absorb the nutrients in food. The enzymes literally break up ... enough to be absorbed by human bodies. According Dr. Henry ... enzymes in regular food is the cause of many gastrointestinal ... started by Michelle DelPresto, a mother of 3 who is ...
Breaking Medicine News(10 mins):Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 4Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:New Super Digestive Enzyme, DZ10, Supercharges The Digestion Process 2
... 2011-For many young scientists, particularly women, research careers hang ... that the American Society for Cell Biology (ASCB) hopes ... grant from Nature Publishing Group (NPG) to underwrite childcare ... next five years. The awards help ensure the continuation ...
... Salk Institute for Biological Studies have found clues to the ... protein, p53, can cause cells to stop dividing or even ... and it is responsible for much of the tissue destruction ... as the ones commonly used for cancer therapy. The new ...
... News) -- Parents who smoke are more likely to try to ... chances of success aren,t any better than normal, a new study ... role in helping these parents quit smoking, said the researchers at ... children who lived with at least one person who smoked in ...
... than whites to receive critical stroke treatment primarily because ... for time-sensitive treatment and because of preexisting medical conditions. ... racial disparity was found. Those are the findings ... the review of almost 1,000 patient records from all ...
... Reporter , THURSDAY, June 30 (HealthDay News) -- You,re probably ... never happened, especially if you,re around people who recall things ... novel false-memory test and brain-scanning technology to find out how ... took part in the test believed the implanted memories -- ...
... DIEGO, CA In order to recognize and encourage ... the American Orthopaedic Society for Sports Medicine (AOSSM) will ... Annual Meeting, July 7-10 in San Diego, California. ... provides more than $300,000 to research initiatives and projects ...
Cached Medicine News:Health News:Nature Publishing Group supports ASCB Childcare Awards for scientist-parents at annual meeting 2Health News:The genome guardian's dimmer switch: Regulating p53 is a matter of life or death 2Health News:The genome guardian's dimmer switch: Regulating p53 is a matter of life or death 3Health News:A Child's Surgery May Prompt Parents to Try to Quit Smoking 2Health News:Georgetown research identifies key reasons racial disparities exist in emergent stroke treatment 2Health News:Group-Think Can Influence Your Memory, Research Shows 2Health News:AOSSM presents prestigious research awards at annual meeting 2Health News:AOSSM presents prestigious research awards at annual meeting 3Health News:AOSSM presents prestigious research awards at annual meeting 4
... positive locking rail mounting system features a ... up and down movement, adjusting the armboard ... changing the pad. The Armboard provides easy ... of O.R. Table, and the secure positive ...
... carbon fiber armboard is easily ... table siderail. Durable construction eliminates ... enclosed within molded body, protecting ... Molded carbon fiber allows for ...
Inquire...
Stainless steel construction to withstand sterilization modalities (autoclave, EtO, Steris®, and Sterrad®) Fully autoclavable, with both distal and proximal ends uniquely soldered for longe...
Medicine Products: